K906-2035 Screening compound: 6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

K906-2035 Screening compound: 6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one
K906-2035 Screening compound: 6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound K906-2035
6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K906-2035

Molecular Formula

C31H33ClN4O5S (C31 H33 ClN4 O5 S)

Compound Name

6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

IUPAC name

6-[(3-{4-[(4-chlorophenyl)(phenyl)methyl]piperazine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-23-dihydro-13-benzoxazol-2-one

SMILES

CN(c(ccc(S(N(CCC1)CC1C(N(CC1)CCN1C(c1ccccc1)c(cc1)ccc1Cl)=O)(=O)=O)c1)c1O1)C1=O

InChI

InChI=1S/C31H33ClN4O5S/c1-33-27-14-13-26(20-28(27)41-31(33)38)42(39,40)36-15-5-8-24(21-36)30(37)35-18-16-34(17-19-35)29(22-6-3-2-4-7-22)23-9-11-25(32)12-10-23/h2-4,6-7,9-14,20,24,29H,5,8,15-19,21H2,1H3

InChI Key

WCYPBDBGENCHJG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15112674

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

609.15

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.395

Distribution Coefficient, logD

4.394

Water Solubility, LogSw

-4.98

Polar Surface Area

73.958

Acid Dissociation Constant (pKa)

22.98

Base Dissociation Constant (pKb)

4.96

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.50

K906-2035 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with K906-2035 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K906-2035?
Check Price and Availability of K906-2035, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K906-2035 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K906-2035
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K906-2035
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K906-2035 available by request